Showing results (2041-2050 of 2,517) with videos related to

Sort By:
Pageof 252
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi|November 28, 2021
[Effects of porcine acellular dermal matrix combined with human epidermal stem cells on wound healing of full-thickness skin defect in nude mice]X H Zhao, Y C Guo, H H Chen, et al.
Archives of Virology|May 9, 2018
Triple combination of FDA-approved drugs including flufenamic acid, clarithromycin and zanamivir improves survival of severe influenza in miceAndrew C Y Lee, Kelvin K W To, Anna J X Zhang, et al.
Scientific Reports|October 31, 2013
Discontinuous properties of current-induced magnetic domain wall depinningX F Hu, J Wu, D X Niu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 21, 2026
[Short-term efficacy and safety of neoadjuvant immunotherapy for locally advanced colon cancer with deficient mismatch repair]S B Lu, W J Yang, G J Chen, et al.
Scientific Reports|July 7, 2015
Atomic-Scale Interfacial Magnetism in Fe/Graphene HeterojunctionW Q Liu, W Y Wang, J J Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2022
Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated SPP1+ Macrophages and FibroblastsAnuja Sathe, Kaishu Mason, Susan M Grimes, et al.
Nature Communications|July 17, 2020
Tuning the hysteresis of a metal-insulator transition via lattice compatibilityY G Liang, S Lee, H S Yu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|March 18, 2024
[Mid-term analysis of prospective cohort study of rivaroxaban in preventing CRT in breast cancer]D Sang, S M Fan, S Y Li, et al.
Zhonghua Yi Xue Za Zhi|June 18, 2019
[Quantitative dynamic contrast enhancement MR imaging parameters in the prediction and evaluation of the treatment response of malignant sinonasal tumors to chemotherapy:a preliminary result]Q H Chen, X Y Wang, B Zhang, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2010
Preclinical characterization of the antiviral activity of SCH 900518 (narlaprevir), a novel mechanism-based inhibitor of hepatitis C virus NS3 proteaseX Tong, A Arasappan, F Bennett, et al.
Pageof 252